38.67 0.00 (0.00%)
After hours: 4:00PM EST
|Bid||38.69 x 1300|
|Ask||38.73 x 1100|
|Day's Range||37.81 - 39.60|
|52 Week Range||32.02 - 55.22|
|Beta (5Y Monthly)||1.71|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 28, 2020 - May 03, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||54.60|
Beta Bionics, Inc. — a medical technology company developing and aiming to commercialize the world’s first fully automated bionic pancreas system called the iLet® today announced that Martha G. Aronson and Sean D. Carney have been appointed to the Company’s Board of Directors effective immediately.
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at three upcoming conferences. Webcasts of each of the presentations will be made available on CSI’s website at https://investors.csi360.com/events-and-presentations/events-calendar/default.aspx.
If you own shares in Cardiovascular Systems, Inc. (NASDAQ:CSII) then it's worth thinking about how it contributes to...
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 5.) Alector Inc (NASDAQ: ALEC ) (announced granting ...
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -233.33% and 0.65%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Cardiovascular Systems (CSII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2020 second-quarter conference call on Wednesday, February 5, 2020, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss results for its fiscal second quarter ended December 31, 2019, and its financial outlook. CSI will issue a post-market earnings release prior to the call on February 5, 2020.
If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can significantly...
How do we determine whether Cardiovascular Systems Inc (NASDAQ:CSII) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data shows […]
Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
We are upbeat about the year-over-year uptick in both Coronary and peripheral device revenues within Cardiovascular Systems' (CSII) domestic market.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 29) Cabaletta Bio Inc (NASDAQ: CABA ) Edwards Lifesciences ...
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -88.89% and 0.72%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Is Cardiovascular Systems Inc (NASDAQ:CSII) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after […]